Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by KayDayon Nov 24, 2010 10:41pm
291 Views
Post# 17754902

8 US Patents

8 US PatentsHere are the 8 US Patents, all owned soley by SCT... note that two are the same patent (they must have had to change something and refiled it.) Mystery solved!

Patent Number

Title Of Patent

Date Issued

7704737

Oligodendrocyte production from multipotent neural stem cells

April 27, 2010

This invention relates to methods of producing oligodendrocytes from multipotent neural stem cells by using at least one oligodendrocyte promoting factor, particularly granulocyte-macrophage colony stimulating factor, granulocyte colony stimulating factor, interleukin 3 or interleukin

https://www.freepatentsonline.com/7704737.html

7629169

Methods for the production of platelet-derived growth factor-responsive neural precursor cells

December 8, 2009

This invention provides platelet-derived growth factor-responsive neural precursor (PRP) cells and methods of producing such cells in vivo or in vitro. These cells can further be used to generate neurons, oligodendrocytes and/or astrocytes.

https://www.freepatentsonline.com/7629169.html

7604993

Combined regulation of neural cell production

October 20, 2009

This invention relates to a method of selectively producing neural cells, including neurons or glial cells, in vitro or in vivo. Also provided are methods of treating or ameliorating neurodegenerative disease or medical conditions by producing neural cells. Thus, a combination of factors

https://www.freepatentsonline.com/7604993.html

7534765

Pregnancy-induced oligodendrocyte precursor cell proliferation regulated by prolactin

May 19, 2009

The present invention relates to a method to increase oligodendrocytes and oligodendrocyte precursor cells through administration of prolactin or a prolactin inducing agent.

https://www.freepatentsonline.com/7534765.html

7393830

Prolactin induced increase in neural stem cell numbers

July 1, 2008

The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using prolactin. The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunction

https://www.freepatentsonline.com/7393830.html

7368115

Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitar

May 6, 2008

The present invention relates to a method of increasing the number and/or differentiation of neural stem cells and/or neural stem cell progeny using pituitary adenylate cyclase-activating polypetide (PACAP). In a preferred embodiment, additional growth factors are also utilized. The

https://www.freepatentsonline.com/7368115.html

7048934

Combined regulation of neural cell production

May 23, 2006

This invention relates to a method of selectively producing neural cells, including neurons or glial cells, in vitro or in vivo. Also provided are methods of treating or ameliorating neurodegenerative disease or medical conditions by producing neural cells. Thus, a combination of factors

https://www.freepatentsonline.com/7048934.html

7033995

Production of radial glial cells

April 25, 2006

The present invention relates to a method of producing radial glial cells from neural stem cells, particularly by contacting neural stem cells with epidermal growth factor (EGF), fibroblast growth factor 2 (FGF-2) and/or TGF.alpha.. Leukemia inhibitory factor (LIF) and ciliary neurotroph

https://www.freepatentsonline.com/7033995.html

6844312

Production of tyrosine hydroxylase positive neurons

January 18, 2005

The present invention relates to a method of producing neurons that express the enzyme tyrosine hydroxylase (TH) by subjecting neural stem cells to FGF-1, a protein kinase A activator, a protein kinase C activator, and dopamine/L-DOPA. Surprisingly, when forskolin is used as a protein ki

https://www.freepatentsonline.com/6844312.html

Bullboard Posts